P

PathAI pricing

No price is published for AISight, AISight Dx or any algorithm. What a buyer can establish is the structure: the image management system (a research edition and the cleared AISight Dx), PathAI's own algorithms (research use only in the United States) and partner algorithms on the same menu, and separate biopharma services. Partner algorithms are contracted and billed through PathAI, as its chief growth officer said in October 2026. Ownership may change the terms.

PathAI full profile PathAI alternatives

Pricing terms

How PathAI pricing works

Pricing model: Undisclosed. Laboratories license the image management system and algorithms; biopharma sponsors buy algorithm products and trial services, likely on different structures.
Implementation: Not disclosed. The platform is described as cloud based and browser accessible, needing no additional infrastructure, with LIS integration through AISight Link and a published Epic Beaker interface.
Business associate agreement: Not published. The privacy notice says processing of protected health information is governed by customer agreements and business associate agreements as applicable; no agreement, tier or subcontractor terms are published.

Roche announced on 7 May 2026 a definitive agreement to acquire PathAI for $750 million upfront and up to $300 million in milestone payments, and PathAI's home page still describes the deal as pending. How existing agreements carry over under Roche is not published.

Compared on price

PathAI pricing against its alternatives

Published prices for PathAI and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.

All PathAI alternatives →

P
PathAINo published price
I
Indica LabsNo published price
P
ProsciaNo published price
I
Ibex Medical AnalyticsNo published price
P
PaigeNot published (owned by Tempus since August 2025)
A
AiforiaNo published price
T
Tribun HealthNo published price
P
PrimaaNo published price
S
StratipathNo published price

Questions

PathAI pricing, answered

How much does PathAI cost?

PathAI does not publish a price. What a buyer can establish is the structure: the image management system (a research edition and the cleared AISight Dx), PathAI's own algorithms (research use only in the United States) and partner algorithms on the same menu, and separate biopharma services. Partner algorithms are contracted and billed through PathAI, as its chief growth officer said in October 2026.

Does PathAI charge an implementation fee?

Not disclosed. The platform is described as cloud based and browser accessible, needing no additional infrastructure, with LIS integration through AISight Link and a published Epic Beaker interface.

Does PathAI offer a business associate agreement?

Not published. The privacy notice says processing of protected health information is governed by customer agreements and business associate agreements as applicable; no agreement, tier or subcontractor terms are published.